Active, not recruiting
Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
NCT05012371
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- M D Anderson Cancer Center Houston, Texas, United States
- University of Virginia Charlottesville, Virginia, United States